Wellness Shots

Yes. Our physician-led weight management program includes GLP-1 therapies (Semaglutide and Tirzepatide), all under physician oversight. GLP-1 receptor agonists are among the most clinically validated weight loss treatments in obesity medicine history, with average weight reductions of 15 to 17 percent in major trials. A comprehensive clinical review covers the FDA approval, trial data, and efficacy of semaglutide for weight management.

GLP-1 medications are generally prescribed for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, hypertension, or dyslipidemia. Every patient is evaluated individually during a medical consultation. The FDA-approved eligibility thresholds are confirmed by clinical guidelines synthesized in Diabetes Spectrum.

Yes — and the connection goes deeper than aesthetics. Hormonal changes, inflammation, and metabolic shifts that come with weight loss show up on your skin. At Kintsu, we look at both together. Pairing GLP-1 therapy with skin treatments allows us to address results from both the inside and outside simultaneously. A 2025 review in PubMed covers how GLP-1-based therapies extend beyond weight loss into broader metabolic and systemic health.

Your first visit begins with a complimentary consultation where we review your skin history, previous treatments, and goals. Our medical team is involved in every patient's treatment plan. We will walk you through our recommendations, explain why we chose them, and make sure you are completely comfortable before any treatment begins.